Erratum for “Wortmannin as targeted therapeutic agent for the treatment of triple-negative breast cancer”

Therapeutic Agent ◽

Triple Negative ◽

Wortmannin as Targeted Therapeutic Agent for the Treatment of Triple-Negative Breast Cancer

Tropical Journal of Pharmaceutical Research ◽

10.4314/tjpr.v15i1.13 ◽

2016 ◽

Vol 15 (1) ◽

pp. 95

Author(s):

Jian Li ◽

Fei Liu ◽

Yang Liu ◽

Jia-Jun Du ◽

Qi Liu

Keyword(s):

Breast Cancer ◽

Therapeutic Agent ◽

Triple Negative ◽

Abstract 4741: Development of a novel therapeutic agent for breast cancer based on a new pathway analysis of triple-negative breast cancer

10.1158/1538-7445.am2012-4741 ◽

2012 ◽

Author(s):

Minoru Fujimori ◽

Tomoyuki Fujita ◽

Tamio Mizukami ◽

Tadashi Okawara ◽

Kengo Inoue

Keyword(s):

Breast Cancer ◽

Pathway Analysis ◽

Therapeutic Agent ◽

Triple Negative ◽

Novel Therapeutic

Abstract 5571: Antitumor activity of a novel natural therapeutic agent against triple negative breast cancer.

10.1158/1538-7445.am2013-5571 ◽

2013 ◽

Cited By ~ 1

Author(s):

Ritu Arora ◽

Bernard D. Gary ◽

Steven McClellan ◽

Yaguang Xi ◽

Gary Piazza ◽

...

Keyword(s):

Breast Cancer ◽

Antitumor Activity ◽

Therapeutic Agent ◽

Triple Negative

Abstract C110: Applications of patient-derived triple-negative breast cancer xenografts that represent understudied patients in Louisiana in targeted therapeutic research

10.1158/1538-7755.disp18-c110 ◽

2020 ◽

Author(s):

Margarite D. Matossian ◽

Steven Elliott ◽

Hope E. Burks ◽

Maryl Wright ◽

Rachel A. Sabol ◽

...

Keyword(s):

Breast Cancer ◽

Triple Negative ◽

Therapeutic Research ◽

Breast Cancer Xenografts ◽

Glyceollins as novel targeted therapeutic for the treatment of triple-negative breast cancer

Oncology Letters ◽

10.3892/ol.2011.460 ◽

2011 ◽

Vol 3 (1) ◽

pp. 163-171 ◽

Cited By ~ 32

Author(s):

LYNDSAY V. RHODES ◽

SYREETA L. TILGHMAN ◽

STEPHEN M. BOUE ◽

SHUCHUN WANG ◽

HAFEZ KHALILI ◽

...

Keyword(s):

Breast Cancer ◽

Triple Negative ◽

Kinome profiling reveals breast cancer heterogeneity and identifies targeted therapeutic opportunities for triple negative breast cancer

Oncotarget ◽

10.18632/oncotarget.1865 ◽

2014 ◽

Vol 5 (10) ◽

pp. 3145-3158 ◽

Cited By ~ 31

Author(s):

Fares Al-Ejeh ◽

Mariska Miranda ◽

Wei Shi ◽

Peter T. Simpson ◽

Sarah Song ◽

...

Keyword(s):

Breast Cancer ◽

Triple Negative ◽

Cancer Heterogeneity ◽

LHRH-Conjugated Drugs as Targeted Therapeutic Agents for the Specific Targeting and Localized Treatment of Triple Negative Breast Cancer

Scientific Reports ◽

10.1038/s41598-020-64979-1 ◽

2020 ◽

Vol 10 (1) ◽

Cited By ~ 3

Author(s):

J. D. Obayemi ◽

A. A. Salifu ◽

S. C. Eluu ◽

V. O. Uzonwanne ◽

S. M. Jusu ◽

...

Keyword(s):

Breast Cancer ◽

Triple Negative ◽

Therapeutic Agents ◽

Specific Targeting ◽

Localized Treatment ◽

Duality of iron (III) doped nano hydroxyapatite in triple negative breast cancer monitoring and as a drug-free therapeutic agent

Ceramics International ◽

10.1016/j.ceramint.2020.03.231 ◽

2020 ◽

Vol 46 (10) ◽

pp. 16590-16597 ◽

Cited By ~ 1

Author(s):

Tiago P. Ribeiro ◽

Fernando J. Monteiro ◽

Marta S. Laranjeira

Keyword(s):

Breast Cancer ◽

Therapeutic Agent ◽

Triple Negative ◽

Drug Free

Abstract 1316: Targeted therapeutic approach for triple negative breast cancer using paramagnetic nanoparticle

10.1158/1538-7445.am2016-1316 ◽

2016 ◽

Author(s):

Meser M. Ali ◽

Li Zhang ◽

Hassan Bagher Ebadian ◽

James R. Ewing

Keyword(s):

Breast Cancer ◽

Therapeutic Approach ◽

Triple Negative ◽

Chlorin e6-EGF conjugated gold nanoparticles as a nanomedicine based therapeutic agent for triple negative breast cancer

Photodiagnosis and Photodynamic Therapy ◽

10.1016/j.pdpdt.2021.102186 ◽

2021 ◽

Vol 33 ◽

pp. 102186

Author(s):

Maiara L. Castilho ◽

Viviane. P.S. Jesus ◽

Paula F.A. Vieira ◽

Kevin C. Hewitt ◽

L. Raniero

Keyword(s):

Breast Cancer ◽

Gold Nanoparticles ◽

Therapeutic Agent ◽

Triple Negative ◽

Chlorin E6